Stephen S. Arnon

3.8k total citations
46 papers, 2.2k citations indexed

About

Stephen S. Arnon is a scholar working on Neurology, Public Health, Environmental and Occupational Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Stephen S. Arnon has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 16 papers in Public Health, Environmental and Occupational Health and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Stephen S. Arnon's work include Botulinum Toxin and Related Neurological Disorders (38 papers), Neurological disorders and treatments (20 papers) and Streptococcal Infections and Treatments (16 papers). Stephen S. Arnon is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (38 papers), Neurological disorders and treatments (20 papers) and Streptococcal Infections and Treatments (16 papers). Stephen S. Arnon collaborates with scholars based in United States, Finland and Ireland. Stephen S. Arnon's co-authors include Jason R. Barash, James Chin, Karla Damus, Nicholas P. Jewell, Robert Schechter, C L Hatheway, Karen K. Hill, Nir Dover, Susan E. Maslanka and T. F. Midura and has published in prestigious journals such as New England Journal of Medicine, JAMA and PLoS ONE.

In The Last Decade

Stephen S. Arnon

45 papers receiving 2.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Stephen S. Arnon 1.7k 792 566 248 241 46 2.2k
C L Hatheway 1.9k 1.1× 762 1.0× 626 1.1× 398 1.6× 399 1.7× 47 2.7k
S. S. Arnon 1.1k 0.6× 514 0.6× 221 0.4× 473 1.9× 107 0.4× 9 1.6k
T. F. Midura 396 0.2× 112 0.1× 157 0.3× 103 0.4× 55 0.2× 23 759
Holger Schmidt 188 0.1× 93 0.1× 140 0.2× 190 0.8× 10 0.0× 58 1.3k
Thomas Nowak 74 0.0× 91 0.1× 591 1.0× 172 0.7× 94 0.4× 55 2.4k
Sébastien Pili‐Floury 106 0.1× 364 0.5× 127 0.2× 239 1.0× 29 0.1× 57 2.2k
David Zeman 138 0.1× 33 0.0× 29 0.1× 241 1.0× 140 0.6× 74 1.3k
Toni Whistler 82 0.0× 58 0.1× 103 0.2× 331 1.3× 37 0.2× 62 1.4k
Michael Pietsch 28 0.0× 115 0.1× 56 0.1× 336 1.4× 207 0.9× 52 1.6k
Amy D. Proal 494 0.3× 20 0.0× 53 0.1× 416 1.7× 23 0.1× 22 1.4k

Countries citing papers authored by Stephen S. Arnon

Since Specialization
Citations

This map shows the geographic impact of Stephen S. Arnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen S. Arnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen S. Arnon more than expected).

Fields of papers citing papers by Stephen S. Arnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen S. Arnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen S. Arnon. The network helps show where Stephen S. Arnon may publish in the future.

Co-authorship network of co-authors of Stephen S. Arnon

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen S. Arnon. A scholar is included among the top collaborators of Stephen S. Arnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen S. Arnon. Stephen S. Arnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barash, Jason R., et al.. (2022). Dual-Toxin (“Bivalent”) Infant Botulism in California, 1976-2020: Epidemiologic, Clinical, and Laboratory Aspects. The Journal of Pediatrics. 253. 8–13. 3 indexed citations
2.
Dabritz, Haydee A., et al.. (2020). Descriptive Epidemiology of Infant Botulism in California: The First 40 Years. The Journal of Pediatrics. 227. 247–257.e3. 16 indexed citations
3.
Dabritz, Haydee A., et al.. (2020). Seven-Year Case-Control Study in California of Risk Factors for Infant Botulism. The Journal of Pediatrics. 227. 258–267.e8. 13 indexed citations
5.
Jewell, Nicholas P., et al.. (2017). Efficacy of Human Botulism Immune Globulin for the Treatment of Infant Botulism: The First 12 Years Post Licensure. The Journal of Pediatrics. 193. 172–177. 30 indexed citations
6.
Arnon, Stephen S., et al.. (2017). More Clinical Mimics of Infant Botulism. The Journal of Pediatrics. 193. 178–182. 14 indexed citations
7.
Fan, Yongfeng, Jason R. Barash, Jianlong Lou, et al.. (2016). Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H. The Journal of Infectious Diseases. 213(10). 1606–1614. 31 indexed citations
9.
Dabritz, Haydee A., Karen K. Hill, Jason R. Barash, et al.. (2014). Molecular Epidemiology of Infant Botulism in California and Elsewhere, 1976–2010. The Journal of Infectious Diseases. 210(11). 1711–1722. 29 indexed citations
10.
Dover, Nir, Jason R. Barash, Karen K. Hill, Gary Xie, & Stephen S. Arnon. (2013). Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene. The Journal of Infectious Diseases. 209(2). 192–202. 186 indexed citations
11.
Barash, Jason R. & Stephen S. Arnon. (2013). A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins. The Journal of Infectious Diseases. 209(2). 183–191. 222 indexed citations
12.
Dover, Nir, Jason R. Barash, Karen K. Hill, et al.. (2013). Clostridium botulinum Strain Af84 Contains Three Neurotoxin Gene Clusters: Bont/A2, bont/F4 and bont/F5. PLoS ONE. 8(4). e61205–e61205. 34 indexed citations
13.
Hill, Brenna J., et al.. (2010). Universal and specific quantitative detection of botulinum neurotoxin genes. BMC Microbiology. 10(1). 267–267. 28 indexed citations
14.
Barash, Jason R., Jennifer K. Hsia, & Stephen S. Arnon. (2009). Presence of Soil-Dwelling Clostridia in Commercial Powdered Infant Formulas. The Journal of Pediatrics. 156(3). 402–408. 31 indexed citations
15.
Bagramyan, Karine, Jason R. Barash, Stephen S. Arnon, & Markus Kalkum. (2008). Attomolar Detection of Botulinum Toxin Type A in Complex Biological Matrices. PLoS ONE. 3(4). e2041–e2041. 87 indexed citations
16.
Arnon, Stephen S., Robert Schechter, Susan E. Maslanka, Nicholas P. Jewell, & C L Hatheway. (2006). Human Botulism Immune Globulin for the Treatment of Infant Botulism. New England Journal of Medicine. 354(5). 462–471. 254 indexed citations
17.
Arnon, Stephen S., Robert Schechter, Thomas V. Inglesby, et al.. (2001). Botulinum toxin as a biological weapon. JAMA. 285(8). 95 indexed citations
18.
Sullivan, Nadine M., Daniel C. Mills, H. P. Riemann, & Stephen S. Arnon. (1987). Evaluation of the Minitek system for characterization of Bacillus species. Applied and Environmental Microbiology. 53(11). 2680–2682. 5 indexed citations
19.
Arnon, Stephen S., et al.. (1984). Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: Physiologic and pathologic basis. The Journal of Pediatrics. 104(1). 34–40. 45 indexed citations
20.
Arnon, Stephen S., Karla Damus, Barbara Thompson, T. F. Midura, & James Chin. (1982). Protective role of human milk against sudden death from infant botulism. The Journal of Pediatrics. 100(4). 568–573. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026